19th Indonesia International Pharmaceutical Exhibition (IPEX) will be held from October 21–24, 2025 at the Jakarta International Expo (JIExpo). The event covers pharmaceutical ingredients, contract manufacturing, processing technology, packaging machinery, laboratory equipment, and quality control systems. Featuring 200 exhibitors and over 20,000 visitors across 20,000 sqm, it serves as a comprehensive sourcing and networking platform for the pharmaceutical and biotech industries. Organized by PT Pamerindo Indonesia, the exhibition aims to promote technological innovation, regulatory compliance, and sustainable manufacturing in the global healthcare supply chain.
Range of Exhibition
- Pharmaceutical Machinery & Plant Equipment:
Production and processing machinery, packaging equipment, plant and automation systems, pharmaceutical engineering, and cleanroom technology.
- Ingredients & Raw Materials:
APIs, intermediates, natural extracts, excipients, fine chemicals, additives, and custom manufacturing solutions.
- Biotechnology & R&D:
Biopharmaceuticals, formulation technology, contract research services, innovation hubs, and quality control laboratories.
- Laboratory Equipment & Instruments:
Analytical instruments, labware, testing and calibration devices, water treatment systems, and environmental monitoring equipment.
- Packaging Materials & Technology:
Pharma-grade containers, blister packs, labeling systems, sealing solutions, and intelligent packaging innovations.
- Environmental & Quality Management:
Waste management systems, water purification, air filtration, safety and hygiene solutions, and pharmaceutical software for compliance and production tracking.
- Healthcare Products & Accessories:
OTC and healthcare products, medical consumables, pharma infrastructure, and safety equipment.
Target Audience
Pharmaceutical manufacturers, biotech companies, R&D professionals, chemical suppliers, laboratory technicians, quality assurance managers, healthcare product developers, contract manufacturers, packaging engineers, and regulatory authorities.